Showing results (1771-1780 of 2,495) with videos related to

Sort By:
Pageof 250
ACS Nano|March 3, 2020
Tailoring Hot Exciton Dynamics in 2D Hybrid Perovskites through Cation ModificationDaniel B Straus, Sebastian Hurtado Parra, Natasha Iotov, et al.
Cancer Journal (Sudbury, Mass.)|November 6, 2002
Rituximab for aggressive non-Hodgkin's lymphomas relapsing after or refractory to autologous stem cell transplantationDorothy Pan, Craig H Moskowitz, Andrew D Zelenetz, et al.
The Journal of Rheumatology|September 18, 2002
Challenges of estimating health service utilization for osteoarthritis patients on a population levelLeslie R Harrold, Robert A Yood, Walter Straus, et al.
Pharmacoepidemiology and Drug Safety|December 27, 2017
Is patient exposure preapproval and postapproval a determinant of the timing and frequency of occurrence of safety issues?Alexandra C Pacurariu, Christina E Hoeve, Peter Arlett, et al.
Canadian Journal of Kidney Health and Disease|December 20, 2021
Development and Preliminary Psychometric Testing of an Adult Chronic Kidney Disease Self-Management (CKD-SM) QuestionnaireMichelle D Smekal, Maoliosa Donald, Heather Beanlands, et al.
The Journal of Infectious Diseases|September 1, 1992
UV light-induced reactivation of herpes simplex virus type 2 and prevention by acyclovirJ F Rooney, S E Straus, M L Mannix, et al.
International Journal of Audiology|May 10, 2018
The development of a decision aid for tinnitusHelen Pryce, Marie-Anne Durand, Amanda Hall, et al.
British Journal of Clinical Pharmacology|April 20, 2011
Additional safety risk to exceptionally approved drugs in Europe?Arna H Arnardottir, Flora M Haaijer-Ruskamp, Sabine M J Straus, et al.
Clinical Immunology (Orlando, Fla.)|November 1, 2005
HLA B44 is associated with decreased severity of autoimmune lymphoproliferative syndrome in patients with CD95 defects (ALPS type Ia)Marla M Vacek, Alejandro A Schäffer, Joie Davis, et al.
Pageof 250